title: Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary.
authors.affiliation: Institute of Hemostaseology and Transfusion Medicine, City Hospital, Laudwighafen, Germany. peterhellstern@medicusnet.de
authors.forename: P
authors.initials: P
authors.lastname: Hellstern
authors.forename: W M
authors.initials: WM
authors.lastname: Halbmayer
authors.forename: M
authors.initials: M
authors.lastname: Köhler
authors.forename: R
authors.initials: R
authors.lastname: Seitz
authors.forename: G
authors.initials: G
authors.lastname: Müller-Berghaus
mesh_terms: D001779:Blood Coagulation Factors / Q000592:standards / Q000627:therapeutic use*; D020147:Coagulation Protein Disorders / Q000188:drug therapy; D000075202:Contraindications; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy; D011516:Prothrombin / Q000592:standards / Q000627:therapeutic use*; D012015:Reference Standards; D012307:Risk Factors; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy; D014813:Vitamin K Deficiency / Q000188:drug therapy
chemical_list: D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates; D011516:Prothrombin; D006493:Heparin